What is the selling price of Upadacitinib on the market?

Upadacitinib, a Janus kinase (JAK) inhibitor, is used to treat immune diseases such as moderate to severe rheumatoid arthritis (RA), ulcerative colitis, etc. It has been marketed in China and is included in medical insurance. The original drug of upadatinib is usually available in 15mg*28 tablets, and each box is sold for about 2,000 yuan. Due to its remarkable therapeutic effects and being included in the medical insurance catalog, patients can enjoy certain medical insurance reimbursement discounts when paying, which greatly reduces the patient's financial burden.

In the international market, the price of upadatinib is relatively high, especially in developed countries such as Europe and the United States. Taking the European version as an example, each box may cost more than 20,000 yuan. Due to import taxes and other factors, the price of the European version of upadatinib is much more expensive than the domestic original drug. Despite this, demand in the European and American markets is still large, and some patients are willing to bear higher costs due to the therapeutic effects of the drug.

In addition to original drugs, cheaper versions of generic drugs also appear on the market. These generic drugs are produced by pharmaceutical companies in many countries and are basically the same ingredients as the original drugs, so they have similar efficacy. For example, the imitation version produced by Laos Lucius Company sells for about 500 yuan per box. The price may fluctuate due to exchange rate fluctuations. The price of generic drugs is significantly lower than that of brand-name drugs, making them the first choice for many patients, especially those with limited financial conditions or less medical insurance coverage.

Overall, the selling price of upadatinib on the market varies greatly. The price gap between the original drug at home and abroad is significant, while generic drugs provide patients with more economical treatment options. Patients should choose the appropriate version of the drug based on their personal circumstances and financial affordability, combined with the advice of their doctor.

Keyword tags: Upadacitinib, Ruifu,Upadacitinib, price, original drug, generic drug, medical insurance, price difference

Reference materials:https://www.drugs.com/rinvoq.html